Dermatophytosis historical perspective

Revision as of 13:36, 30 June 2017 by Skazmi (talk | contribs)
Jump to navigation Jump to search

Dermatophytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dermatophytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiographic Findings

X-Ray Findings

CT scan Findings

MRI Findings

Ultrasound Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dermatophytosis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dermatophytosis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onDermatophytosis historical perspective

CDC on Dermatophytosis historical perspective

Dermatophytosis historical perspective in the news

Blogs on Dermatophytosis historical perspective

Directions to Hospitals Treating Dermatophytosis here

Risk calculators and risk factors for Dermatophytosis historical perspective

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dermatophytosis has been prevalent since before 1906, at which time ringworm was treated with compounds of mercury or sometimes sulfur or iodine. Hairy areas of skin were considered too difficult to treat, so the scalp was treated with x-rays and followed up with antiparasitic medication.

Historical Perspective

History credits three biologists for the creation of medical mycology: Robert Remak, Johann L. Schönlein, and David Gruby, each of whom studied dermatophytes at one point or another (2). In 1835, Remak observed microscopic structures from crusts of favic lesions (favus is ringworm of the scalp) after which Schönlein identified the specimen having fungal origin (2). Remak ultimately describes the fungi as Achorion schöenleinii in honor of his mentor Schönlein; however it was Gruby who is considered the founder of dermatomycology (2). Independently of Remak and Schönlein, Gruby published papers from 1841 to 1844 about the about the cause and nature of Favus expanding significantly what biologists then knew about dermatophytes (2).

Around 1890, Raimond Sabouraud advanced knowledge of dermatomycology by studying extensively into the taxonomy, morphology, and treatment of dermatophytes, even classifying these fungal agents into four genera (three of which are still current to mycologists) (2). Even more importantly, Sabouraud developed a medium for culturing dermatophytes that, after a few modifications, is even still used today and is named in his honor: Sabouraud glucose agar (2).

References

Template:WikiDoc Sources